Solitaire 2 Revascularization Device, Solitaire Platinum Revascularization Device (Solitaire Revascularization Device)— 510(k) K181807

Substantially Equivalent

Micro Therapeutics, Inc. d/b/a ev3 Neurovascular

FDA 510(k) clearance K181807 for Solitaire 2 Revascularization Device, Solitaire Platinum Revascularization Device (Solitaire Revascularization Device), Substantially Equivalent on 2019-03-06. Applicant: Micro Therapeutics, Inc. d/b/a ev3 Neurovascular. Device class: 2.

Clearance details

Applicant
Micro Therapeutics, Inc. d/b/a ev3 Neurovascular
Product code
Code POL
Device class
Class 2
Regulation
21 CFR 882.5600
Advisory panel
Neurology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Irvine, CA, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code POL

view all

More clearances from Micro Therapeutics, Inc. d/b/a ev3 Neurovascular

view all

Data sourced from openFDA. This site is unofficial and independent of the FDA.